Prognostic factors in 165 elderly colorectal cancer patients

被引:0
作者
Ke-Jun Nan Hai-Xia Qin
机构
关键词
in; or; as; Prognostic factors in 165 elderly colorectal cancer patients; form; of; World; were; that; with; CRC; have;
D O I
暂无
中图分类号
R735.3 [肠肿瘤];
学科分类号
100214 ;
摘要
AIM:To analyse the prognostic factors in 165 colorectapatients aged≥70.METHODS:One hundred and sixty-five elderly patients withcolorectal cancer diagnosed by histology were entered intothe retrospective study between 1994 and 2001.Patientswere given optimal operation alone,chemotherapy afteroperation,or chemotherapy alone according to tumor stage,histology,physical strength,and co-morbid problems.Survival rate was calculated by Kaplan-Meier method,andcompared with meaningful variances by Log-rank method.Prognostic factors were analyzed by Cox regression.RESULTS:The 1,2,3,4,5 year survival rate(all-cause mortality)was 87.76 %,65.96 %,52.05 %,42.77 %,40.51%,respectively.The mean survival time was 41.89±2.33 months(95 % CI:37.33-46.45 months),and the median survivaltime was 37 months.Univariate analysis showed that factorssuch as age,nodal metastasis,treatment method,Duke’sstage,gross findings,kind of histology,and degree ofdifferentiation had influences on the survival rate.Multivariateanalysis showed that factors such as treatment method,Duke’s stage,kind of histology and degree of differentiationwere independent prognostic factors.CONCLUSION:This study suggests that the prognosis ofelderly colorectal cancer patients is influenced by severalfactors.Most of elderly patients can endure surgery and/orchemotherapy,and have a long-time survival and goodquality of life.
引用
收藏
页码:2207 / 2210
页数:4
相关论文
共 19 条
[1]   Colorectal cancer screening for the natural population of Beijing with sequential fecal occult blood test: a multicenter study [J].
李世荣 ;
聂昭华 ;
李楠 ;
李军祥 ;
章萍 ;
杨昭徐 ;
牟善坤 ;
杜亚萍 ;
胡继春 ;
袁申元 ;
屈汉庭 ;
张泰昌 ;
王世鑫 ;
董恩钰 ;
漆德芳 .
Chinese Medical Journal, 2003, (02)
[2]   Importance of response to neoadjuvant chemotherapy in patients undergoing resection of synchronous colorectal liver metastases [J].
Allen, PJ ;
Kemeny, N ;
Jarnagin, W ;
DeMatteo, R ;
Blumgart, L ;
Fong, Y .
JOURNAL OF GASTROINTESTINAL SURGERY, 2003, 7 (01) :109-115
[3]   Investigation of the prognostic value of coexpressed erbB family members for the survival of colorectal cancer patients after curative surgery [J].
Lee, JC ;
Wang, ST ;
Chow, NH ;
Yang, HB .
EUROPEAN JOURNAL OF CANCER, 2002, 38 (08) :1065-1071
[4]   Prognosis and response to therapy in colorectal cancer [J].
Walker, J ;
Quirke, P .
EUROPEAN JOURNAL OF CANCER, 2002, 38 (07) :880-886
[5]  
Patterns of lymphatic spread in rectal cancer. A topographical analysis on lymph node metastases[J] . W.H. Steup,Y. Moriya,C.J.H. van de Velde.European Journal of Cancer . 2002 (7)
[6]  
Efficacy, tolerability and management of raltitrexed (Tomudex?) monotherapy in patients with advanced colorectal cancer[J] . D. Cunningham,J. Zalcberg,J. Maroun,R. James,S. Clarke,T.S. Maughan,M. Vincent,J. Schulz,M. González Barón,T. Facchini.European Journal of Cancer . 2002 (4)
[7]   Counting alleles to predict recurrence of early-stage colorectal cancers [J].
Zhou, W ;
Goodman, SN ;
Galizia, G ;
Lieto, E ;
Ferraraccio, F ;
Pignatelli, C ;
Purdie, CA ;
Piris, J ;
Morris, R ;
Harrison, DJ ;
Paty, PB ;
Culliford, A ;
Romans, KE ;
Montgomery, EA ;
Choti, MA ;
Kinzler, KW ;
Vogelstein, B .
LANCET, 2002, 359 (9302) :219-225
[8]   Clinical significance of serum and urinary c-erbB-2 levels in colorectal cancer [J].
Tsigris, C ;
Karayiannakis, AJ ;
Zbar, A ;
Syrigos, KN ;
Baibas, N ;
Diamantis, T ;
Alexiou, D .
CANCER LETTERS, 2002, 184 (02) :215-222
[9]   Long-term follow-up after surgery for advanced colorectal carcinoma involving the urogenital tract [J].
Stief, CG ;
Jonas, U ;
Raab, R .
EUROPEAN UROLOGY, 2002, 41 (05) :546-550
[10]   Predictive value of thymidylate synthase expression in resected metastases of colorectal cancer [J].
Corsi, DC ;
Ciaparrone, M ;
Zannoni, G ;
Mancini, M ;
Cassano, A ;
Specchia, M ;
Pozzo, C ;
Martini, M ;
Barone, C .
EUROPEAN JOURNAL OF CANCER, 2002, 38 (04) :527-534